Reviva Pharmaceuticals Holdings (RVPH) Interest Coverage Ratio (2023 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Interest Coverage Ratio of 491.8 for Q1 2026, down 177.66% sequentially from 633.28 in Q4 2025, and up 12.59% YoY from 436.79 in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Interest Coverage Ratio for 4 years, with the latest figure at 491.8 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 12.59% year-over-year to 491.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2007.57 (down 116.3% YoY) and the FY2025 annual result came in at 0.57, up 41.54% from the prior year.
- Interest Coverage Ratio fell to 491.8 in Q1 2026 per RVPH's latest filing, from 633.28 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 633.28 in Q4 2025 and troughed at 1577.65 in Q2 2024.
- A 4-year average of 662.03 and a median of 562.66 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio tumbled 4276.65% in 2024, then surged 147.47% in 2025.
- Over 4 years, Interest Coverage Ratio stood at 942.33 in 2023, then tumbled by 41.57% to 1334.03 in 2024, then soared by 147.47% to 633.28 in 2025, then slumped by 177.66% to 491.8 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 491.8, 633.28, and 1546.96 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - | -891.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -891.84 |
| Mar 31, 2026 | -491.80 |
| Dec 31, 2025 | 633.28 |
| Sep 30, 2025 | -1,546.96 |
| Jun 30, 2025 | -1,266.00 |
| Mar 31, 2025 | -562.66 |
| Dec 31, 2024 | -1,334.03 |
| Sep 30, 2024 | -101.32 |
| Jun 30, 2024 | -1,577.65 |
| Mar 31, 2024 | -431.72 |
| Dec 31, 2023 | -942.33 |
| Sep 30, 2023 | -36.77 |
| Jun 30, 2023 | -36.05 |
| Mar 31, 2023 | -912.44 |